首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   2607857篇
  免费   236407篇
  国内免费   14086篇
耳鼻咽喉   35763篇
儿科学   81421篇
妇产科学   66442篇
基础医学   439077篇
口腔科学   69359篇
临床医学   232571篇
内科学   440831篇
皮肤病学   76593篇
神经病学   230662篇
特种医学   102323篇
外国民族医学   30篇
外科学   411490篇
综合类   86861篇
现状与发展   23篇
一般理论   2027篇
预防医学   224208篇
眼科学   58792篇
药学   175925篇
  22篇
中国医学   8551篇
肿瘤学   115379篇
  2022年   22674篇
  2021年   54421篇
  2020年   34721篇
  2019年   57641篇
  2018年   69101篇
  2017年   52517篇
  2016年   57816篇
  2015年   72740篇
  2014年   106803篇
  2013年   171739篇
  2012年   69406篇
  2011年   65703篇
  2010年   110090篇
  2009年   116498篇
  2008年   52920篇
  2007年   52769篇
  2006年   64908篇
  2005年   60385篇
  2004年   62765篇
  2003年   54159篇
  2002年   44240篇
  2001年   58726篇
  2000年   49946篇
  1999年   59084篇
  1998年   60992篇
  1997年   59919篇
  1996年   57043篇
  1995年   52642篇
  1994年   46822篇
  1993年   43933篇
  1992年   38076篇
  1991年   35741篇
  1990年   33024篇
  1989年   33534篇
  1988年   31493篇
  1987年   30667篇
  1986年   29172篇
  1985年   30567篇
  1984年   32650篇
  1983年   31314篇
  1982年   36308篇
  1981年   34692篇
  1980年   32763篇
  1979年   24845篇
  1978年   25478篇
  1977年   24414篇
  1976年   22064篇
  1975年   19890篇
  1974年   18636篇
  1973年   17935篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
151.
152.
153.
154.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
155.
156.
157.
158.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
159.
Depigmented lesions may occur as postinflammatory sequelae of subacute cutaneous lupus erythematosus (SCLE), leading to great psychosocial impact. A 53‐year‐old male patient presented with post‐SCLE depigmented facial lesions after five years of disease stability. We proposed surgical treatment with melanocyte‐keratinocyte transplantation procedure (MKTP), and after five months the patient achieved 90% repigmentation, without Koebner phenomenon (KP). In theory, KP is a possible complication of MKTP procedure since the preparation of the receptor area involves the use of dermabrasion. In an attempt to avoid it, we suggest to maintain the treatment of the underlying disease and wait for a minimum period of disease stability before the procedure.  相似文献   
160.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号